Aquestive Therapeutics (AQST) Return on Capital Employed Growth (5y) (2023 - 2026)
Aquestive Therapeutics (AQST) Return on Capital Employed Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.51 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.58 Bn | 23.52 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.02 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.94 Bn | 16.63 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn |
| 10 | Aquestive Therapeutics | 461.63 Mn | 461.63 Mn | 13.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,172.00 |
| Dec 31, 2025 | 5,854.00 |
| Sep 30, 2025 | 4,208.00 |
| Jun 30, 2025 | -36.00 |
| Mar 31, 2025 | 4,595.00 |
| Dec 31, 2024 | 8,136.00 |
| Sep 30, 2024 | 16,506.00 |
| Jun 30, 2024 | 14,041.00 |
| Mar 31, 2024 | 11,514.00 |
| Dec 31, 2023 | 5,061.00 |
| Sep 30, 2023 | 3,650.00 |